March 1, 2021
March 1, 2021 – Merck, the manufacturer of Keytruda® (pembrolizumab), has voluntarily withdrawn the
drug’s FDA-approved indication to provide third-line treatment of metastatic small cell
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health News
February 28, 2021
February 28, 2021 – The U.S. FDA has approved NulibryTM (fosdenopterin), manufactured by BridgeBio
Pharma, to reduce the risk of death due to molybdenum cofactor deficiency (MoCD) Type A
February 27, 2021
The U.S. FDA has granted Emergency Use Authorization (EUA) to Johnson & Johnson’s
COVID-19 vaccine, which is manufactured by the Johnson & Johnson subsidiary
February 26, 2021
February 26, 2021 – The U.S. FDA has approved Pepaxto® (melphalan flufenamide), manufactured by Oncopeptides, for use in conjunction with dexamethasone to treat relapsed or
February 25, 2021
February 25, 2021 - Since the start of the pandemic, affordable and sustainable access to oxygen has been a growing challenge in low- and middle-income countries.
February 25, 2021
February 25, 2021 – The U.S. FDA has approved Amondys 45TM (casimersen), manufactured by Sarepta Therapeutics, to treat Duchenne muscular dystrophy (DMD) in patients who have a
February 25, 2021
February 25, 2021 – The U.S. FDA has relaxed temperature requirements for the transportation and storage of the COVID-19 vaccine from Pfizer and BioNTech. The vaccine can now be
February 24, 2021
February 24, 2021 – The U.S. FDA has approved an expanded indication for Humira® (adalimumab), manufactured by AbbVie. Humira is now indicated to treat moderately to severely